Amicus Therapeutics, Inc.
FOLD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$56,106 | -$151,584 | -$236,568 | -$250,460 |
| Dep. & Amort. | $8,547 | $7,873 | $5,342 | $6,209 |
| Deferred Tax | $0 | -$4,939 | $9 | $34 |
| Stock-Based Comp. | $84,905 | $86,077 | $76,512 | $57,838 |
| Change in WC | -$98,943 | -$47,990 | -$39,880 | -$18,585 |
| Other Non-Cash | $27,706 | $41,472 | $28,010 | $2,473 |
| Operating Cash Flow | -$33,891 | -$69,091 | -$166,575 | -$202,491 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,553 | -$7,440 | -$3,766 | -$3,884 |
| Net Acquisitions | $0 | $0 | $3,411 | $0 |
| Inv. Purchases | -$114,786 | -$91,723 | -$243,255 | -$341,398 |
| Inv. Sales/Matur. | $117,779 | $197,227 | $335,926 | $424,043 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$560 | $98,064 | $92,316 | $78,761 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$97 | -$20,958 | -$283 | -$479 |
| Stock Issued | $27,243 | $92,935 | $4,310 | $199,750 |
| Stock Repurch. | $0 | $0 | -$11,490 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$22,025 | -$10,300 | $0 | $12,802 |
| Financing Cash Flow | $5,121 | $61,677 | -$7,463 | $212,073 |
| Forex Effect | -$4,031 | $6,312 | -$14,619 | -$5,049 |
| Net Chg. in Cash | -$33,361 | $96,962 | -$96,341 | $83,294 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $250,077 | $153,115 | $249,456 | $166,162 |
| End Cash | $216,716 | $250,077 | $153,115 | $249,456 |
| Free Cash Flow | -$37,444 | -$76,531 | -$170,341 | -$206,375 |